Alessandra Cesano
CIK 1827015 · View on SEC EDGAR ↗
First SEC filing: Feb. 9, 2024 · Latest: June 15, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2026 | PBYI | A | 27,000 | — | — | 68,850 Direct | +64.52% | Acquired | (price as of 2026-08-20) |
| Jan. 12, 2026 | ZYME | A | 7,700 | — | — | 7,700 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 12, 2026 | ZYME | A | 11,500 | — | — | 11,500 Direct | — | Acquired | (price as of 2026-08-20) |
| Dec. 10, 2024 | ZYME | A | 31,000 | — | — | 31,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 8, 2024 | ZYME | A | 74,000 | — | — | 74,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | ZYME | Restricted Stock Unit | Common Stock (7,700) | — | Jan. 12, 2027 | 7,700 | Acquired |
| Jan. 12, 2026 | ZYME | Stock Option (Right to Buy) | Common Stock (11,500) | $23.16 | Jan. 11, 2036 | 11,500 | Acquired |
| Dec. 10, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock (31,000) | $13.06 | Dec. 9, 2034 | 31,000 | Acquired |
| Feb. 8, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock (74,000) | $11.47 | Feb. 7, 2034 | 74,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.